Bajaj Harpreet S - Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic

基本信息

浏览量：14

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 156 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Oral Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial

Nikolaus Marx, John E Deanfield,Johannes F E Mann, Rosario Arechavaleta,Stephen C Bain,Harpreet S Bajaj, Katrine Bayer Tanggaard,Andreas L Birkenfeld,John B Buse, Zaklina Davicevic-Elez,Cyrus Desouza,Scott S Emerson, Mads D M Engelmann,G Kees Hovingh,Silvio E Inzucchi,Pardeep S Jhund,Sharon L Mulvagh,Rodica Pop-Busui, Neil R Poulter,Søren Rasmussen,Shih-Te Tu,Darren K McGuire, SOUL Study Group

Circulation（2025）

引用0浏览0WOS引用

Efficacy and Hypoglycaemia Outcomes with Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin in Individuals with Type 2 Diabetes by Kidney Function: A Post Hoc Participant-Level Analysis of the ONWARDS 1-5 Trials

Peter Rossing, Malik Benamar, Y, Bharath Kumar,Christian Laugesen,Harpreet S Bajaj

Diabetes, obesity & metabolismno. 4 (2025): 2259-2270

引用0浏览0WOS引用

Chronic Kidney Disease in Diabetes: A Clinical Practice Guideline

Sheldon W Tobe,Harpreet S Bajaj,Navdeep Tangri, Rahul Jain, Thuy Pham, Valerie Beaudin,Phil McFarlane, Diabetes Canada Clinical Practice Guideline Steering Committee

Canadian journal of diabetesno. 2 (2025): 73-86.e14

引用0浏览0WOS引用

Metformin As First-line Therapy: Response to Drs Trinacty and Goldenberg

Baiju R Shah,Harpreet S Bajaj,Sonia Butalia,Kaberi Dasgupta,Dean T Eurich, Rahul Jain,Kerry Mansell, Scot Simpson

Canadian journal of diabetesno. 1 (2025): 3-4

引用0浏览0WOS引用

CGM Chez Des Patients DT2 Insulinotraités Switchés Pour L’insuline Icodec Hebdomadaire Vs Comparateurs Journaliers : Post-Hoc Des Études ONWARDS 2 Et 4

F. Zummo,B. Ásbjörnsdóttir,H.S. Bajaj,C. Laugesen,C. Mathieu,A. Philis-Tsimikas, N. Wang,T. Battelino

Annales d'Endocrinologieno. 5 (2024): 502-503

引用0浏览0引用

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials

Sheldon W. Tobe,Thomas A. Mavrakanas,Harpreet S. Bajaj,Adeera Levin,Navdeep Tangri,April Slee,Brendon L. Neuen,Vlado Perkovic,Kenneth W. Mahaffey,Wally Rapattoni,Fernando G. Ang

DIABETES CARE（2024）

引用3浏览0WOS引用

826-P: Efficacy and Safety of Once-Weekly Insulin Icodec Vs. Once-Daily Basal Insulin in Individuals with Type 2 Diabetes by Kidney Function—ONWARDS 1–5

PETER ROSSING, MALIK BENAMAR, ALICE Y.Y. CHENG,CHRISTIAN LAUGESEN, PERNILLE HØJLUND NIELSEN,HARPREET S. BAJAJ

Diabetes（2024）

引用0浏览0引用

Gastrointestinal Adverse Events and Weight Reduction in People with Type 2 Diabetes Treated with Tirzepatide in the SURPASS Clinical Trials

Hiren Patel,Kamlesh Khunti,Helena W. Rodbard,Harpreet S. Bajaj,Ross Bray, Zbigniew Kindracki,Angel Rodriguez

DIABETES OBESITY & METABOLISM（2024）

引用8浏览0WOS引用

Durée D’hypoglycémie Similaire Avec Icodec Vs Degludec Ou Glargine U100 Chez Les Patients DT2 Insulinotraités : Analyse CGM Post-Hoc D’onwards 2 Et 4

F. Zummo,T. Battelino,B. Ásbjörnsdóttir,L. Carstensen,C. Laugesen,C. Mathieu,A. Philis-Tsimikas,H.S. Bajaj

Annales d'Endocrinologieno. 5 (2024): 502

引用0浏览0引用

Insulin Efsitora Versus Degludec in Type 2 Diabetes Without Previous Insulin Treatment

Carol Wysham,Harpreet S. Bajaj,Stefano Del Prato,Denise Reis Franco, Arihiro Kiyosue,Dominik Dahl, Chunmei Zhou,Molly C. Carr, Michael Case, Livia Firmino Goncalves

NEW ENGLAND JOURNAL OF MEDICINEno. 23 (2024): 2201-2211

引用2浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn